Firms To Watch: Industry focus: Healthcare and life sciences

Industry focus: Healthcare and life sciences in France

ALCHIMIE AVOCATS

Jointly steered by healthcare and life sciences heads Mathilde Merckx and Xavier Lebrasseur, the team at ALCHIMIE AVOCATS provides particular expertise in anti-gift issues and data protection matters within the healthcare, pharmaceuticals and biotech sectors.

A&O Shearman

A&O Shearman has a comprehensive healthcare and life sciences offering, allowing the team to advise clients across the pharmaceuticals, finance, biotech, medtech and healthcare sectors. Typical mandates for the team include M&A transactions, infringement lawsuits, patent litigation and regulatory data protection advice. Laëtitia Bénard, who spearheads the practice, is an experienced litigator, well regarded in the market for her expertise in handling multi-jurisdictional and national patent disputes for major pharmaceutical companies. Charles Tuffreau brings strong expertise in validity and infringement issues, advising clients across the full remit of cross-border litigation and preliminary injunction proceedings.

Responsables de la pratique:

Laëtitia Bénard


Autres avocats clés:

Charles Tuffreau


Les références

‘The team provide very clear advice on possible outcomes, and are able to switch strategy if new reasonable arguments appear.’

‘Laëtitia Bénard communicates clearly and always takes different perspectives into consideration. She works relentlessly on a given task.’

Principaux clients

Bayer


Organon


LFB


Crédit Mutuel Equity


IQVIA


Yusen Logistics


Merz


Principaux dossiers


  • Representing a global pharmaceutical and healthcare company in the protection of its supplementary protection certificate (SPC) for the combination of sitagliptin and metformin, addressing challenges posed by multiple generic companies seeking to launch their generic products.
  • Advising Yusen Logistics Group, a subsidiary of NYK, on the execution of a put option agreement for the acquisition of the healthcare logistics business of the Walden Group, for a total amount of approximately EUR1.25 billion.
  • Assisting and representing a global pharmaceutical and healthcare company in multiple infringement lawsuits brought against numerous major generic companies based on a patent covering one of the client’s blockbusters for the treatment of several types of cancer.

ADVANT Altana

ADVANT Altana is home to an experienced healthcare and life sciences team whose varied case load ranges from M&A transactions to IP protection and contractual matters, with the team showcasing a strong track record in litigation, including pharmaceutical anti-competition and regulatory non-compliance cases. The practice group is co-led by Armand Aviges, a seasoned litigator in product liability matters, particularly complex serial claims, and Jean-Nicolas Soret, who focuses on private cross-border M&A transactions in the biotech and medtech industries. Gilles Gaillard is a name to note for clients seeking advice on corporate finance transactions, acquisitions or disposals of assets.

Responsables de la pratique:

Armand Aviges; Jean-Nicolas Soret


Autres avocats clés:

Gilles Gaillard; Delphine Lapillonne


Les références

‘The team are very knowledgeable in French product liability litigation.’

‘Armand Aviges is highly committed to his clients.’

‘A cohesive and highly skilled team; approachable and collaborative. They have extensive knowledge of civil law, particularly in the area of product liability, where we collaborate with them on several cases.’

‘Good level of resources associated with complex and sensitive cases. Contribution to an innovative digital approach to the management of collective and individual claims in the medical field.’

‘Armand Aviges, Delphine Lapillonne and their colleagues possess remarkable expertise and working methodology in high-profile litigation of unparalleled legal complexity.’

Principaux clients

CFAO Group


Biophytis


Cowen Healthcare Investments


CSRP (Chambre Syndicale de la Répartition Pharmaceutique)


Sapio Group


In’Tech Medical SAS


Laboratoire Synbionyme


Leem


Pharmalex


Proclinic


Sancare


Soredip


Stryker


Laboratorio Farmaceutico Erfo


Uriage


Xerys


Principaux dossiers


  • Advised the management of Kurma Partners on the contemplated sale of the remaining 30% of the shares in Kurma Partners to Eurazeo.
  • Advising LEEM, the professional organisation of pharmaceutical companies in France, in relation to various prospective issues regarding the evolution of French law, the implementation of EU directives, and draft bill proposals.
  • Advising CFAO Healthcare on the contemplated acquisition of the remaining 70% of the shares in Africa Chemist and Beauty Care Inc.

Dechert LLP

One of the pre-eminent law firms in France for healthcare and life sciences, Dechert LLP is regularly instructed by pharmaceutical and biotechnology companies, as well as laboratories and nursing homes. Clients regularly turn to the team for assistance with regulatory compliance, pricing matters, product liability complaints, and complex life sciences and pharmaceutical litigation. Co-heading the practice, Mélanie Thill-Tayara is an experienced litigator, well-known in the market for handling antitrust and competition matters at EU and French level for major life sciences, pharmaceutical and healthcare clients, while Alain Decombe’s broad expertise extends across the full remit of corporate transactions. Sophie Pelé has in-depth knowledge of litigation in strategic market access cases.

Responsables de la pratique:

Alain Decombe; Mélanie Thill-Tayara


Autres avocats clés:

Sophie Pelé


Les références

‘Sophie Pelé is a leading expert in life sciences regulatory law. With exemplary availability and unwavering enthusiasm, she combines in-depth legal expertise with a keen understanding of the sector’s realities.’

‘On the most complex cases, Sophie Pelé distinguishes herself through a strategic, pragmatic, and solution-oriented approach, making her a trusted partner. She accurately grasps commercial issues, anticipates litigation risks with foresight, and is adept at communicating with regulatory authorities.’

‘The team possesses cutting-edge expertise in addressing complex issues. The team benefits from a network of regulatory partners in key European countries, enabling the management of regional cases.’

Principaux clients

ARCHIMED


Abivax


Chiesi Farmaceutici S.P.A


Poxel


Roche


Stragen France


Virbac


Principaux dossiers


  • Advised Virbac Santé Animale in its successful complaint before the European Commission to challenge a “killer acquisition” made by Zoetis.
  • Advised Abivax on US$747.5 million public offering on Nasdaq.
  • Advised Poxel on its non-dilutive financing agreement with OrbiMed for US$50 million, including the monetization of Poxel’s future royalties.

Dentons

A pre-eminent healthcare and life sciences firm, Dentons is regularly turned to by pharmaceutical companies, biotech and medtech firms, and healthcare providers. Led by Jean-Marc Grosperrin, Julien Le Guyader and Anne-Laure Marcerou, the department continues to advise on M&A transactions, marketing rights, regulatory advice, patent protection and FTO analyses. Grosperrin is regularly sought after by international pharmaceutical groups, while Le Guyader specialises in licensing and market access issues, and Marcerou provides expertise in representing foreign and domestic private equity funds engaging in life sciences investments. Jessica Garestier stands out for her work across the full remit of regulatory matters.

Responsables de la pratique:

Jean-Marc Grosperrin; Julien Le Guyader; Anne-Laure Marcerou


Autres avocats clés:

Jessica Garestier


Les références

‘The team provides excellent legal advice, with a practical approach focused on finding solutions. I would also highlight the immediate availability and responsiveness of the team, and their capacity to advise on complex legal matters from all angles.’

‘Anne-Laure Marcerou: outstanding and highly experienced lawyer with a deep knowledge of the healthcare industry, always keen to provide pragmatic solutions.’

‘The team is highly specialized in healthcare transactions, having worked with the main players in the industry in France and therefore being very aware of the specificities of each player. This is critical in the negotiation phase of the transaction, as they quickly understand the needs of the counterparty and where they are likely to cave.’

Principaux clients

Septodont


Pfizer


Laboratoires Servier


Théa Open Innovation


Laboratoires Coloplast


H.A.C Pharma


Gilde Healthcare


MabSilico


Eos Imaging


Sparta


Sofinnova


KPS Capital Partners


ESTEVE


Lisi Group


Principaux dossiers


  • Advised a long-standing client Laboratoires Servier on preparing the proposed sale of Biogaran and steered the project through vendor due diligence, transaction structuring, and high-level buyer engagement.
  • Advised Esteve on acquiring exclusive marketing rights to Caprelsa® (vandetanib) across 50+ countries.
  • Advised Septodont on the acquisition of a 51% majority stake in Laboratorios Inibsa, alongside Acteon, strengthening their position in the dental pharmaceuticals market across Spain, Portugal, and France.

Hogan Lovells (Paris) LLP

With a particularly active healthcare and life sciences practice, Hogan Lovells (Paris) LLP’s team is recognised for its expertise in matters relating to competition law, regulatory compliance, healthcare data processing, product liability and commercial litigation. At the helm of the practice, Mikael Salmela covers the entire scope of the product lifecycle in the pharmaceutical, biotech and medical device sectors, undertaking matters ranging from advising on clinical trial frameworks to negotiating high-value commercial agreements. Charlotte Damiano is regularly called upon by clients for regulatory and market access matters, as well as representing pharmaceutical and medical device companies in pricing and reimbursement disputes.

Responsables de la pratique:

Mikael Salmela


Autres avocats clés:

Charlotte Damiano; Joséphine Pour


Les références

‘A strong team with in-depth expertise on access and commercialization.’

‘Charlotte Damiano is an exceptional expert.’

‘The Hogan Lovells team is unique in that it includes members specializing in both healthcare law and data protection law. This dual expertise is essential for companies in the pharmaceutical sector and allows us to understand our legal environment comprehensively. This dual specialization is rare in this industry and sets Hogan Lovells apart from other firms in the support it offers.’

‘Joséphine Pour is a lawyer who stands out for her expertise in health law, pharmaceutical law, health regulations, and data protection law. Her strengths include in-depth expertise in several areas, excellent client relationship skills, and her willingness to take on new cases and answer our questions, as well as her meticulous case management.’

‘While we worked with a team, we truly were impressed with Mikael Salmela, who was truly exceptional as a partner. We would highly recommend him.’

‘The team demonstrate a very solid and broad professional expertise; immediate responsiveness; and a proactive approach.’

Principaux clients

Alexion Pharma


Rovi


Biogen


Merck & Co., Inc., and its French subsidiary MSD Vaccins


Hollister Inc.


F. Hoffmann La Roche AG


Principaux dossiers


  • Assisted Alexion Pharma in a dispute that lasted approximately 10 years, seeking a reversal of the French Supreme Court’s (Cour de Cassation) historic case law on the deduction of rebates paid to the health insurance fund from the turnover of laboratories subject to social security contributions.
  • Assisting Merck & Co., Inc., and its French subsidiary MSD Vaccins, in the coordination and defence of product liability claims brought by French plaintiffs before the courts or before Commissions for Conciliation and Indemnification (CCIs) in relation to alleged adverse events of the vaccines Gardasil or Gardasil 9.
  • Assisted Rovi in challenging a clause imposed by the Economic Committee for Health Products, which is responsible for negotiating pharmaceutical products’ prices, requiring future price decreases to be aligned with generic comparators.

McDermott Will & Schulte

McDermott Will & Schulte’s healthcare and life sciences practice spans an array of sectors, including biotech, biopharmaceuticals, medtech and venture capital. The team is recognised for its expertise in R&D collaboration and licensing agreements, M&A transactions, and cross-border regulatory pathways work. The department is under the leadership of Emmanuelle Trombe, who is well regarded for the depth of her expertise in advising on joint ventures and strategic collaborations in both France and the United States. Anthony Paronneau advises on a wide array of corporate finance transactions and corporate securities.

Responsables de la pratique:

Emmanuelle Trombe


Autres avocats clés:

Anthony Paronneau; Sophie Lafay; Anne-France Moreau


Les références

‘Excellent command of the health and life sciences sector, combining legal rigour with an operational understanding of scientific issues.’

‘Anthony Paronneau stands out for his in-depth knowledge of the healthcare and biotech sectors, his rigorous legal expertise, and his strategic vision for public-private partnerships and translational research. He combines a highly human and collaborative approach, making him a trusted partner.’

‘The team has a strong command of our field and is extraordinarily efficient. They are always available and responsive to requests. They are an approachable and very pleasant team to work with. Despite being a smaller organization, we feel that we receive work of equally high quality and efficiency.’

‘Sophie Lafay is incredibly efficient, while Anthony Paronneau has unparalleled availability and exceptional mastery of our field of activity and the news that concerns it.’

‘Anthony Paronneau has a very sharp and well-honed business acumen, enabling him to advise both very large organizations and smaller ones like ours with agility and pragmatism.’

‘Anthony Paronneau and Anne-France Moreau are recommended for their pragmatism and understanding of the market.’

‘Anthony Paronneau, Anne-France Moreau, and Emmanuelle Trombe: In my opinion, these three partners embody a versatile, complementary, and highly responsive team. They possess excellent expertise in transactional, corporate, and regulatory matters.’

‘Anne-France Moreau is remarkable for her availability, strategic thinking, and in-depth knowledge of the healthcare sector. She distinguishes herself through a highly personalized approach to cases and an ability to anticipate clients’ needs. She possesses true strategic intelligence in complex negotiations.’

Principaux clients

Novo Nordisk


Laboratoire Delbert


Spotlight Medical


Abolis Biotechnologies


Osivax


Novartis Groupe France SAS


Myonex


Owkin


Biocorp


MaaT Pharma


Sensorion


Corteria Pharmaceuticals


Cilcare


Aboleris Pharma


Orano Med


Orakl Oncology


Aqemia


L’Oréal


Servier


Pierre Fabre


Principaux dossiers


  • Advised Pierre Fabre on an exclusive R&D collaboration and licence agreements with RedRidge Bio, seeking to identify and develop biparatopic antibody (BPA) drug candidates against multiple targets.
  • Advised Orano Med on the signing of an exclusive licensing agreement with Sanofi and Radiomedix to develop AlphaMedix, a next-generation radioligand therapy for rare cancers, including neuroendocrine tumours.
  • Advised Novo Nordisk on the French aspects of its acquisition of Catalent.

Simmons & Simmons

Simmons & Simmons’ wide-ranging practice encompasses regulatory compliance, M&A and contract negotiation, with a noted expertise in pharmaceutical product liability. The practice is jointly led by experienced partners Jacques-Antoine Robert and Alexandre Regniault. Robert has a high level of experience and knowledge in the pharmaceutical industry, acting for clients in regulatory matters, transactions and disputes. Regniault is a reference for pharmaceutical, medical device and biotech clients across the full range of contentious and non-contentious matters, from licensing negotiations to breach of contract litigation. Ombline Ancelin stands out for her work in competition law, while Simonetta Giordano specialises in joint ventures and commercial contracts.

Responsables de la pratique:

Jacques-Antoine Robert; Alexandre Regniault


Autres avocats clés:

Ombline Ancelin; Simonetta Giordano


Les références

‘Jacques-Antoine Robert demonstrates availability, professionalism, attentiveness, support, responsiveness, and a proactive approach.’

‘Focused on building sustainable long term relationships with clients. This leads to deep relationships and knowing we can count on Simmons & Simmons to be responsive. The targeted learning and information they share with us about our specific sector is also deeply appreciated – they demonstrate an understanding of what is important to us.’

Principaux clients

Merck Santé


Merck Serono


Servier


DomusVi


Rhythm Pharmaceuticals


Bayer Healthcare


Cooper Consumer Health


Eisai


Amgen


Principaux dossiers


August Debouzy

August Debouzy maintains an active presence in the healthcare and life sciences sector, with the team standing out for its experience in complex intellectual property issues, particularly patent litigation. The group is led by the capable quartet of François Pochart, Grégoire Desrousseaux, Lionel Martin and Hélène Billery. Pochart is an experienced patent litigator, regularly representing clients before the domestic courts and the UPC. Desrousseaux is a name to note in EPO litigation and licensing issues, while Martin specialises in matters within the medical devices industry. Billery frequently assists pharmaceutical and biotechnology clients on regulatory and compliance issues.

Responsables de la pratique:

François Pochart; Grégoire Desrousseaux; Lionel Martin; Hélène Billery


Les références

‘François Pochart demonstrates expertise, professionalism, responsiveness, creativity and pragmatism.’

Principaux clients

A-Tract


Abbott Diabetes Care


Metex Noovistago


Sofibel


Biomérieux


DBV Technologies


Alcon


B Braun


Becton Dickinson


Ceva Santé Animale


Disphar (Nordic Pharma Group)


Ferring


Fresenius kabi


Gilson


Insulet


Inserm Transfert


Laboratoires Majorelle


LFB


Maïa Africa


Medtronic


Nipro


Nuvamid


Novasep


Teva


Teoxane


Wright Medical


jaide


Principaux dossiers


  • Represented Fresenius in an infringement action initiated against biosimilars competitors on the French market, notably against Biogen.
  • Represented Teva in two preliminary injunctions brought by Biogen following the launch at risk of Teva’s generic products of Biogen’s Dimethyl fumarate product (Tecfidera®).
  • Advised jaide on the implementation of data processing activities in compliance with data protection and healthcare regulations.

Baker McKenzie

Baker McKenzie’s wide-ranging healthcare and life sciences practice encompasses regulatory compliance, M&A transactions, and licensing and contractual matters across the biotech, medical devices, pharmaceuticals and healthcare sectors. Spearheading the practice, Julie Yeni covers a broad scope of work, which ranges from advising on regulatory procedures in clinical trials to market access matters. Marie-Françoise Bréchignac advises on a wide range of multi-jurisdictional corporate transactions, while Ludivine Naulleau is prepared to handle the full lifecycle of health products, from medical devices to cosmetics, including marketing authorisation and pharmaceutical licensing. Melodie Truong and Marion de Galembert are key figures within the team.

Responsables de la pratique:

Julie Yeni


Autres avocats clés:

Marie-Françoise Bréchignac; Ludivine Naulleau; Melodie Truong; Marion de Galembert


Les références

‘The team are reliable, responsive and professional.’

‘Julie Yeni is extremely responsive, pleasant, and very competent, demonstrating knowledge of the field, availability, and adaptability.’

‘Julie Yeni showcases open-mindedness, availability and knowledge of the field.’

Principaux clients

AbbVie


Galapagos


Johnson & Johnson


Laboratoires Servier


New Mountain Capital


Safe Life AB


Principaux dossiers


  • Represented Servier in a global licensing agreement with Black Diamond Therapeutics for the development and commercialization of a treatment.
  • Advised Safe Life AB on the acquisition of D-Sécurité Groupe SAS and France DAE.

Bird & Bird

Bird & Bird's healthcare and life sciences team is jointly steered by Emmanuelle Porte and Anne-Charlotte Le Bihan. The group is recognised for its expertise in IP and patent litigation, advising companies across the biotech, medtech, digital health and technology sectors. The team’s strategic transactions capabilities are also noteworthy. Porte has established experience handling venture capital, M&A and corporate finance transactions, as well as advising clients on the structuring of joint ventures. Le Bihan brings significant experience in both contentious and non-contentious IP matters to the team, in particular, specialising in pan-European patent litigation within the pharmaceutical industry. Johanna Harelimana has broad experience, extending from clinical trial and market access matters to regulatory advice on phytopharmaceuticals.

Responsables de la pratique:

Emmanuelle Porte; Anne-Charlotte Le Bihan


Autres avocats clés:

Johanna Harelimana


Les références

‘The team showcases responsiveness and professionalism.’

‘Emmanuelle Porte stands out for her professionalism, the quality of her advice, and her responsiveness.’

Principaux clients

NovAliX


Novo Nordisk


CorWave


Sparing Vision


Edwards Lifesciences


Dexcom


Moon Surgical


Implanet


IQVIA


Biosency


Shoebox


Adalvo


Orphalan


La Science/ Science Corp


Brainever


Juvisé Pharmaceuticals


Tilak Healthcare


Lesaffre


Advicenne


Enterome


Principaux dossiers


  • Representing Edwards Lifesciences in a major patent dispute implying the infringement of five European patents covering a transcatheter heart valve.
  • Representing bioMérieux in a disparagement case before the Lyon Commercial Court.
  • Advising Coave Therapeutics on its Series A2 financing round led by Bpifrance and Novo Holding A/S, which also included Invus and UI Investissement, alongside existing investors Seroba Life Sciences, Fund+, Kurma Partners, Omnes Capital and Turenne Capital.

De Gaulle Fleurance & Associés

De Gaulle Fleurance & Associés is home to a highly experienced healthcare and life sciences team, whose cross-practice approach draws on the firm’s wider strengths in IP, IT, data protection, competition, and AI to advise clients across the biopharmaceutical, animal health, pharmaceutical, digital tech and medtech sectors. The practice is co-headed by experienced practitioners Jean-Marie Job, Cécile Théard-Jallu and Francine Le Péchon-Joubert. Job is a reference for pharmaceutical and biotechnology clients regarding regulatory compliance, market access and contractual matters. Théard-Jallu is well versed in complex R&D and consortium contractual transactions, while Le Péchon-Joubert specialises in defending trademark portfolios.

Responsables de la pratique:

Jean-Marie Job; Cécile Théard-Jallu; Francine Le Péchon-Joubert


Les références

‘The most unique and impressive feature of De Gaulle Fleurance & Associés’s healthcare and life sciences practice is its close cross-disciplinary collaboration between relevant teams, such as the regulatory, transactional, IP and data teams.’

‘My contact at the firm is Cécile Théard-Jallu. She has a very detail-oriented and attentive character. I value it very much.’

‘A highly responsive team demonstrating strong flexibility and attentiveness to the challenges faced by their clients in the healthcare and life sciences sector.’

‘Strong expertise in the health and life sciences sector.’

Principaux clients

Alliance digitale maladiecoronavirus.fr


Bouchara Recordati


CEGEDIM


CFAO Healthcare


CIP


Echosens


Genopole


Genoway


Gilead Sciences


Hyperion


Institute For Smart Health


SoFIA -Santé


Principaux dossiers


Delsol Avocats

Delsol Avocats’ healthcare and life sciences team is particularly impressive in handling health data issues, including gaining authorisations from the CNIL and managing consortium health data warehouse matters. The firm is also skilled in advising on anti-corruption frameworks and regulatory compliance. The practice group is co-headed by experienced practitioners Jeanne Bossi Malafosse, who specialises in personal data protection matters, and Gaëlle Merlier, who is well known in the market for advising pharmaceutical companies, medical device manufacturers and clinical laboratories on M&A transactions. Aura Braun advises on a wide array of regulatory issues.

Responsables de la pratique:

Jeanne Bossi Malafosse; Gaëlle Merlier


Autres avocats clés:

Aura Braun


Les références

‘They are responsive, receptive and clear in their communications. The quality of the advice is good.’

‘The multidisciplinary nature of the Delsol team and their comprehensive and pragmatic vision allow us to approach our various subjects with peace of mind, with a single point of contact.’

Principaux clients

Abbott France


Argiletz


AstraZeneca


Bioptimus


Calmedica


Centre Hospitalier Intercommunal Toulon – La Seyne-sur-Mer


CNGE


CNOP (Conseil National de l’Ordre des Pharmaciens)


Conseil National de l’Ordre des Masseurs Kinésithérapeutes (CNOMK)


Dactys


Docaposte


Fondation Mérieux


Impact Healthcare


Ipsen


IVC Evidencia


Leem


Medident


Otsuka Pharmaceutical France


Simago


Takeda


Principaux dossiers


  • Advised the National College of Teaching General Practitioners (CNGE) on obtaining authorisation from the French Data Protection Authority (CNIL) for the Platform for Data in Primary Care (P4DP) project, a data warehouse hosting general medicine data.
  • Advised Centre Hospitalier Intercommunal Toulon – La Seyne-sur-Mer (CHITS) regarding the sell-off of Clinique Sainte-Marguerite de Hyères’ activities.

DLA Piper

DLA Piper continues to handle instructions from clients in the pharmaceuticals, financial services, medical devices, laboratory and healthtech sectors. The team’s wide-ranging expertise encompasses M&A transactions, drafting and negotiating strategic agreements, and advising on the full remit of regulatory issues. Spearheading the practice, Sonia De Kondserovsky is well known in the market for transactional matters ranging from acquisitions of listed and non-listed companies to corporate restructurings. Guillaume-Denis Faure is an experienced healthcare litigator, regularly representing clinics, hospitals and laboratories, while Denise Lebeau-Marianna specialises in regulatory compliance matters, particularly strategic data governance projects.

Responsables de la pratique:

Sonia de Kondserovsky


Autres avocats clés:

Guillaume-Denis Faure; Denis Lebeau-Marianna; Paul L’Huillier


Les références

‘The team stands out for its responsiveness, its understanding of business challenges, and its mastery of complex regulatory issues.’

‘Guillaume-Denis Faure is a trusted advisor whom we consult on all strategic matters. The clarity and insight of his analysis are complemented by a strong business acumen and pragmatic solutions.’

‘Paul l’Huillier is promising: clear, instructive, and with a strong understanding of regulations.’

‘The team is highly committed to its clients. It has extensive experience in strategic alliances within the healthcare sector. Being part of an international network, particularly in the USA, is a significant advantage given the size of the American market and the US expertise in this field.’

‘The multidisciplinary nature of the DLA Piper team (corporate, M&A, regulatory, dispute resolution, healthcare and life sciences) and their comprehensive and pragmatic vision allow us to approach our various issues with confidence, with a single point of contact.’

Principaux clients

Pierre Fabre


Sanofi/Opella


Laboratoires Vivacy


Synlab France


Sanofi


Stryker


Eurazeo (Nov Santé)


Principaux dossiers


  • Advising Sanofi and Opella on the carveouts and operational contracts for the industrial disentanglement of Opella and Sanofi businesses at site level on an international scale, including in Tunisia, Brazil, Mexico, the US and Japan.
  • Assisted Synlab France on the sale of four of its subsidiaries, including the sale of Synlab Lorraine, to a regional biology group.

Fieldfisher

Fieldfisher is home to a highly experienced healthcare and life sciences team, catering to clients across the biocontrol, digital health, pharmaceutical and medtech sectors. The firm’s work covers transactional, regulatory, and contentious matters, ranging from involvement in AI-driven clinical research to complex pharmaceutical litigation and M&A transactions. Leading the team, Olivier Lantrès is well known in the market for litigation in highly regulated sectors. Marguerite Brac de la Perrière is a reference for SaaS medical devices manufacturers, pharmaceutical companies and insurers seeking advice across the full remit of regulatory and digital health issues. Nathalie Hadjadj-Cazier stands out for her strategic advice on, and defence of, IP rights.

Responsables de la pratique:

Olivier Lantrès


Autres avocats clés:

Marguerite Brac de la Perrière; Nathalie Hadjadj-Cazier


Les références

‘Marguerite Brac de la Perrière is innovative, available, responsive, diplomatic, and an expert in her field.’

‘Skill, availability and responsiveness.’

‘Olivier Lantrès demonstrates great professionalism, excellent technical skills and extreme responsiveness and availability.’

Principaux clients

Sumitomo (Philagro France)


Suterra Europe Biocontrol S.L.


Deleo


Zoll


GLEAMER


ECHOSENS


Zentiva


Owkin, Inc.


Recordati


BIOGARAN


Principaux dossiers


  • Represented Philagro France and Suterra Europe Biocontrol S.L. in two high-profile administrative litigation cases before the French courts against ANSES, challenging the agency’s refusal to grant or renew marketing authorisations for key phytopharmaceutical and biocontrol products.
  • Advising Echosens, the manufacturer of FibroScan®, on its digital health and compliance strategy, providing ongoing support on IT and digital health matters, including IT contracts, tech distribution agreements, general terms of service, and data protection compliance.
  • Successfully represented Deleo before the Paris Court of Appeal in a case involving allegations of unfair competition and regulatory non-compliance brought by BTL.

Gide Loyrette Nouel A.A.R.P.I.

Gide Loyrette Nouel A.A.R.P.I. has a comprehensive healthcare and life sciences offering, allowing the team to advise on financing, capital markets, IP, M&A transactions and competition law. Raphaëlle Dequiré-Portier is an experienced litigator, specialising in domestic and pan-European patent and trademark disputes. Paul Jourdan-Nayrac specialises in cross-border M&A and private equity matters, while Arnaud Duhamel brings an in-depth knowledge of debt capital markets and strategic equity derivatives transactions. Farah El-Bsat is also noted for her expertise in complex project finance and venture debt financing for biotech and medtech companies.

Autres avocats clés:

Raphaëlle Dequiré-Portier; Paul Jourdan-Nayrac; Arnaud Duhamel; Farah El-Bsat; Jean-Hyacinthe De Mitry; Marie-Ange Pozzo Di Borgo; Aurélie Pacaud


Les références

‘An independent, high quality firm offering top quality patent litigation advice.’

‘Raphaëlle Dequiré-Portier is very knowledgeable and at the top of her game.’

‘Jean-Hyacinthe De Mitry is confident, commercial and comfortable with the most difficult of issues.’

‘Marie-Ange Pozzo Di Borgo is very quick witted and possess deep experience beyond her years.’

‘The team stands out for its in-depth knowledge of our industry, enabling it to quickly grasp our challenges and provide targeted, pragmatic solutions. Its exceptional responsiveness is a true asset, as is its ability to bring together complementary and specialized profiles, perfectly aligned with our needs.’

‘The firm’s combination of industry expertise, agility, and interpersonal skills makes it a strong and distinctive team in the market, capable of offering reliable, innovative, and results-oriented support.’

‘Aurélie Pacaud brings great rigour and a strategic vision.’

‘Large, high-quality, and highly competent team, particularly in the health and life sciences sectors, notably for pharmaceutical patent litigation. Extensive experience and expertise in SPCs. Excellent communication with patent attorneys to prepare litigation files. Works in synergy.’

Principaux clients

Imaneo


Apollo Global Management


Bristol Myers Squibb (BMS)


Bryan, Garnier & Co


Cathay Innovation


Dreem SAS


Elsan


Gensight Biologics


Heal Capital


Inventiva


Isalt


LifeSci Capital


Meril Life Sciences


Ono Pharmaceutical


Orpea


Phaxiam Therapeutics


Phoenix Group


SVB Securities


Principaux dossiers


HOYNG ROKH MONÉGIER

Cross-border IP litigation is at the heart of HOYNG ROKH MONEGIER’s healthcare and life sciences practice. The practice continues to handle instructions from clients in the pharmaceutical, biotech, medical devices and biopharmaceutical sectors. The group is under the joint leadership of Benoît Strowel and Anne Servoir: Strowel is an experienced litigator in both France and Belgium who excels in multi-jurisdictional patent litigation, while Servoir showcases strong credentials in competition law and regulatory matters within the pharmaceutical and biotech industries. Sabine Agé is a reference for biotech, pharmacy, chemistry and medical devices clients.

Responsables de la pratique:

Benoît Strowel; Anne Servoir


Autres avocats clés:

Sabine Agé


Les références

‘We have had a very good experience working with them. We have received good advice from skilled lawyers and have been very satisfied with their work.’

‘We have had a good dialogue and received very good advice and support. They have been able to understand our case and what is needed from their side.’

Principaux clients

AorticLab


Illumina


Institut National de la propriété industrielle


Regeneron


Takeda


Principaux dossiers


jasper Avocats

jasper Avocats' practice spans an array of industries, including medtech, pharmaceutical, medical software, hospital and health products. The team’s varied case load ranges from undertaking due diligence relating to fund raisings and acquisitions, to health product and medical liability litigation. The practice group is co-led by experienced partners Olivier Saumon, who specialises in pharmaceutical law, health product regulation and EU distribution law, and Céline Roquelle-Meyer, who focuses on medical biology matters, particularly governance structures. Jean-François Laigneau has a high level of experience and knowledge in the health products industry.

Responsables de la pratique:

Olivier Saumon; Céline Roquelle-Meyer


Autres avocats clés:

Jean-François Laigneau; Emmanuelle Burkic


Les références

‘The team are recommended for their knowledge of the sector and their availability.’

‘Our contact person was Jean-François Laigneau, who was particularly attentive to our expectations, demonstrating strong expertise, responsiveness, quality of service and adaptability.’

‘Jean-François Laigneau is excellent in his field, with a thorough knowledge of the subject matter, both technically and practically, and a very good understanding of the market and its players. He demonstrated a practical and pragmatic approach, with good communication skills in both French and English.’

‘Jean-François Laigneau possesses exceptional technical skills. He is a valuable asset in healthcare law. His technical expertise and pragmatism are particularly appreciated by clients. Communication is very smooth.’

‘The team distinguishes itself through its rare and cross-disciplinary expertise in healthcare law applied to telemedicine innovation. It has a thorough understanding of regulatory issues.’

‘Excellent cohesion among partners. Céline Roquelle-Meyer is very accessible and has excellent interpersonal skills.’

‘A traditional yet effective and reliable approach. Conviction conveyed through well-structured and reasoned written arguments, reinforced by an undeniable presence in court.’

‘The team anticipate regulatory changes and develop strategies that are always one step ahead.’

Principaux dossiers


  • Advised on a series of cases for financial investors in medical groups, including medical biology, radiology, cardiology, veterinary clinics or health centres, with a view to ensuring the legal security of their investment.
  • Advising one of the largest national medical biology groups on all its corporate and regulatory issues.

LexCase

LexCase’s wide-ranging healthcare and life sciences practice encompasses product liability litigation, regulatory compliance issues, market access matters and marketing rights negotiations. The group is led by a capable quartet: Diane Bandon-Tourret, Alain de Belenet, Raphaël Apelbaum and Maxime Büsch. Bandon-Tourret combines significant experience in the pharmaceutical sector with wide-ranging expertise encompassing regulatory issues and litigation. De Belenet excels in public contract law and market access matters, while Apelbaum specialises in alternative dispute resolution in relation to public health procurement contracts. Büsch is a name to note for litigation relating to the liability of public entities.

Responsables de la pratique:

Diane Bandon-Tourret; Alain de Belenet; Raphaël Apelbaum; Maxime Büsch


Les références

‘A highly responsive team who are close to the client.’

‘Diane Bandon-Tourret is always available, very clear, seeks solutions, and shares her contacts outside the EU.’

‘The team in the Paris office offers comprehensive expertise and an exclusive focus on regulatory and reimbursement issues in the healthcare and life sciences sector, which is a unique selling point in the market.’

‘The team has an extensive network across all areas of the healthcare and life sciences industry, as well as a comprehensive understanding of the scientific aspects, which is combined with a practical and client-oriented approach to counselling.’

‘Working with Diane Bandon-Tourret is always a benefit thanks to her comprehensive knowledge and extensive expertise. She has a thorough understanding of how to put innovative drugs and therapies into practice.’

‘Diane Bandon-Tourret’s business-oriented and practical advice particularly stand out. Her deep understanding of the market and her network are unique selling points and extremely valuable to us. She also provides invaluable support as a representative in court during litigation.’

‘Diane Bandon-Tourret’s responsiveness and quick thinking is unparalleled in the French market!’

‘A responsive team, with expertise in all sensitive issues related to the life sciences sector.’

Principaux clients

Fujifilm


Medtronic


Philips France Commercial


Philips Koninklijke NV


Pierre Fabre Group


Pierre Fabre Dermo-Cosmetique


Pierre Fabre Medicament


Olympus


Essilor International


Colgate Palmolive


SNITEM


Coloplast


Horizon Therapeutics


Biologique Recherche


GrandVision


CHU Nice


Medtronic International


Principaux dossiers


  • Assisting and advising a leading international medical devices group regarding the withdrawal and replacement of life saving devices and other devices worldwide, following the implementation of a full-scale field safety corrective action, before the competent authorities and French courts, in particular in the context of a major collective action.
  • Assisting several clients of the Conference Bleue Network in their discussions with the National Agency for the Safety of Medicines (ANSM) to obtain marketing rights for the French market through derogatory proceedings.

Norton Rose Fulbright

Norton Rose Fulbright’s healthcare and life sciences team is jointly steered by Marta Giner Asins and Karine Montagut, with the team’s varied case load including regulatory compliance, antitrust matters, and digital and data privacy issues. Asins is a reference for pharmaceutical clients, acting in both major litigation and M&A transactions. Montagut regularly advises domestic and international clients on acquisitions and disposals, while Christian Dargham leads the firm’s disputes practice on matters concerning product liability. Nadège Martin is recommended for handling cross-border data privacy issues.

Responsables de la pratique:

Marta Giner Asins; Karine Montagut


Autres avocats clés:

Christian Dargham; Nadège Martin


Principaux clients

Pfizer


Ramsay Santé


Sanofi


Abbott


Medtronic


SYNLAB


Embecta


Principaux dossiers


  • Assisting a leading French pharmaceutical company in respect of an early access authorization related to gene therapies in France and advised on related data protection issues.
  • Advising a leading French pharmaceutical laboratory on licensing-in transactions of e-health products, solutions in the heart failure, oncological and neurological fields.

Reed Smith

Reed Smith maintains a strong position in the healthcare and life sciences market, with the team’s wide-ranging expertise encompassing product liability litigation, competition compliance risk assessments and tender disputes. The group is co-headed by Natasha Tardif, Marc Lévy and Daniel Kadar. Tardif has strong credentials in advising on competition law issues within the pharmaceutical sector, as well as advising on merger notifications. Lévy specialises in antitrust litigation and competition compliance, while Kadar stands out for his work in complex litigation and cross-border disputes.

Responsables de la pratique:

Daniel Kadar; Marc Lévy; Natasha Tardif


Principaux dossiers


Winston & Strawn LLP

Winston & Strawn LLP has a comprehensive healthcare and life sciences offering, allowing the team to advise on PE-backed M&A transactions, strategic partnerships, regulatory litigation and the full remit of contractual matters. The practice group is co-led by experienced partners Gilles Bigot, who specialises in strategic litigation, cybersecurity issues in healthcare and public-private partnerships, and Julie Vern Cesano-Gouffrant, who is noted for the depth of her expertise in complex domestic and cross-border transactions. Rim Khirddine is frequently sought out by health care facilities, clinics, and assisted living communities to advise on regulatory compliance.

Responsables de la pratique:

Gilles Bigot; Julie Vern Cesano-Gouffrant


Autres avocats clés:

Rim Khirddine


Les références

‘A brilliant, available and welcoming team.’

‘Gilles Bigot is especially strategic. Julie Vern Cesano-Gouffrant is especially strong at thinking through the « chess board » of potential strategic moves.’

‘Gilles Bigot and Julie Vern Cesano-Gouffrant demonstrate responsiveness and remarkable results.’

‘Gilles Bigot and Julie Vern Cesno-Gouffrant provide personalised, competent support and are accessible to everyone.’

‘A close-knit, highly experienced team committed to changing case law and transforming the healthcare system.’

‘Very responsive team, with expert knowledge in medical business. Sharp analysis and help during the process.’

‘Very strong knowledge of the market, great mix of deep understanding, strategic thinking and practical application.’

Principaux clients

Biofutur


EverImmune


Imapole


Ipsos


JUUL Labs


La Croix Rouge Française


Ogènes


Omnes


Oradianse


Bridgepoint


PointVision


Proveca


Ramsay Générale de Santé


Sarah Santé Group


Abenex Capital SA


Telemos Capital / MedEuropa


Capital Croissance


CRF Jeanne d’Arc


MBO & Co.


Dentius


Core Equity Holdings


Medipass


Centres de Médecine Nucléaire


PlusDental


Principaux dossiers


  • Representing Imapôle in high-profile litigation before the French Council of State.
  • Advising Telemos Capital—through its radiotherapy platform, Stingray—on the structuring and expansion of its operations in France since inception.
  • Advising the Evesio CMN Group on the integration of physicians into its professional partnerships and on the structuring of investment schemes to benefit the group’s internal medical partners.

BCTG Avocats

BCTG Avocats’ cross-functional healthcare and life sciences practice encompasses regulation, competition, distribution and intellectual property matters across the pharmaceutical, medtech, biotech and OTC product laboratory sectors. François Dauba showcases expertise in drafting and negotiating commercial contracts for pharmaceutical clients, while Hugues Villey-Desmeserets regularly represents clients before professional associations and criminal courts. Gaëlle Bloret-Pucci is an experienced IP litigator, and Séverin Kullmann advises domestic and international clients on private equity transactions.

Responsables de la pratique:

François Dauba; Hugues Villey-Desmeserets; Gaëlle Bloret-Pucci; Caroline Goupil; Séverin Kullmann; Aymeric Malphettes; Sabine de Paillerets; Cyprien Dufournier


Les références

‘The team are very responsive. They listen to the client’s needs and constraints, are proactive, and do not hesitate to make suggestions.’

‘We work with Séverin Kullman and his team. They are very available, involved, and proactive. Their knowledge of M&A and our industry means that their advice is always sound and relevant.’

‘Sabine de Paillerets demonstrated responsiveness, attentiveness, a proactive approach and reliability.’

‘A competent, diligent, proactive, and very pleasant team.’

‘I appreciate and commend the availability and responsiveness of the team.’

‘A closely-knit, dynamic and responsive team, adapting to cutting-edge technologies and surrounding itself with the necessary experts.’

‘The team suggest innovative approaches, and are both serious and professional.’

‘The team demonstrate good knowledge of the healthcare and retail sectors, a pragmatic approach and responsiveness.’

Principaux clients

Genosafe


NHCO Nutrition


Zentiva


PLG


Pharmonweb


Pharmedisound


Pharma LCA Consortium


Infecto Pharma


Sandoz


Uriage


EssilorLuxottica


Ceva


Melisana Pharma


Teva Santé


Iktos


EG427


PathoQuest


Takeda Shire


ISLO Santé


Kenvue


Principaux dossiers


  • Advised the Pharma LCA Consortium to ensure that its activities comply with the competition rules applicable to standardization agreements and sustainability agreements, and that the relationship between the consortium and public authorities or other organizations developing competing standards complies with competition rules.
  • Advised Nozin on the launch of a new product on the French market, manufactured and distributed in the USA.
  • Advised several generic and biosimilar drug laboratories on overhauling their communications policy and defining their commercial policy in anticipation of expected regulatory changes.

Clifford Chance

Clifford Chance’s healthcare and life sciences group handles a wide array of litigation, involving product liability, IP, antitrust and employment disputes. The practice also continues to assist clients in navigating regulatory matters, ranging from advertising to anti-gift matters. Marianne Pezant is a key contact for domestic and international corporations, private equity firms and financial institutions seeking advice on strategic M&A and private equity transactions. Laurent Schoenstein showcases in-depth knowledge of governance and regulatory constraints pertinent to consolidated groups of medical practitioners, while David Tayar is an experienced antitrust litigator. Health data expert Patrice Navarro is also a name to note.

Responsables de la pratique:

Marianne Pezant; Laurent Schoenstein; David Tayar


Autres avocats clés:

David Por; Patrice Navarro


Les références

‘The team are attentive, serious, proactive, and knowledgeable in their field.’

Principaux clients

Agria Vet Guide AB


Andera Partners


Archimed


Ares Capital


Cathay Capital


Cinven


dsm-firmenich


Five Arrows (Chronos Dental)


GenFit SA


Gland Pharma


Kurma Partners


Lauxera Capital


Merck


MGI


Mitsui & Co


Neuraxpharm


Novartis


Pfizer


Point Vision


Sofinnova Partners


Stada


Teva Pharmaceuticals


Teva Santé


Unilabs France


Principaux dossiers


Goodwin

Goodwin is home to a highly experienced healthcare and life sciences team, capable of advising clients on strategic acquisitions, joint ventures, fundraising and cross-border transactions. Spearheading the team, Anne-Charlotte Rivière specialises in venture capital, M&A and private equity transactions. Marie Fillon is a name to note for strategic partnerships, including licences, collaborations, and distribution agreements. Maxence Bloch brings in-depth knowledge of M&A transactions, in particular leveraged buyouts and private equity transactions.

Responsables de la pratique:

Anne-Charlotte Rivière


Autres avocats clés:

Marie Fillon; Maxence Bloch; Thomas Dupont Sentilles; Guilhem Richard


Les références

‘Marie Fillon has deep knowledge of the life sciences start-up sector in France.’

‘An efficient team, capable of leading large-scale M&A projects by mobilizing the right experts.’

‘Anne-Charlotte Rivière is recommended for her availability, listening skills, empathy, good interpersonal skills, and expertise.’

‘The team is very well coordinated and is able to provide services immediately when needed.’

‘The team at Goodwin thinks 3-4 steps ahead of the companies they represent and they provide solutions for problems that have not yet taken form. This is very important as the pace of my company is fast and it is easy for me and the leadership team to misstep during the rush. Goodwin has kept us well protected and they have placed us in a good position for the future.’

‘Expertise in understanding the underlying issues. Close client relationships. High-quality team.’

‘Marie Fillon has the ability to be business-oriented – a rare quality because IP is very often focused on patent creation and less on their day-to-day management in contracts.’

‘Thomas Dupont Sentilles has extensive experience in growth phases for high-growth companies.’

Principaux clients

AlgoTx


AQEMIA


Biomunex


Cerba Healthcare


GENFIT


Germitec


Moon Surgical


Stilla Technologies


TRICares


UroMems


AdBio Partners


Andera Partners


Cathay Capital


EMZ Partners


Eurazeo


IK Partners


Karista


Kindred Ventures


Kurma Partners


Novo Holdings


Sofinnova Partners


Principaux dossiers


  • Advising Stilla Technologies on its acquisition by Bio-Rad.
  • Advising Genfit on a non-dilutive capped royalty financing agreement with HealthCare Royalty (HCRx) for up to €185 million in exchange for a portion of the royalties on sales of Iqirvo® (elafibranor).
  • Adivising TRICares on its $50 million Series D financing round.

HBC Avocats

Structuring transactions and negotiating and drafting commercial and transactional agreements are at the heart of HBC Avocats’ healthcare and life sciences practice. The practice group is co-led by experienced partners Jonathan Burnham, who has a high level of experience and knowledge in licensing, partnership and clinical trial agreements, and Erwan Cossé, who specialises in M&A and venture capital transactions. Fabrice Herbin is also a key name to note.

Responsables de la pratique:

Jonathan Burnham; Erwan Cossé


Autres avocats clés:

Fabrice Herbin


Les références

‘Jonathan Burnham is very experienced and often comes up with proposals that are interesting both legally and business-wise.’

‘Fabrice Herbin has the client’s best interests at heart and holds firm where we might sometimes be ready to give up in order to finalize a contract.’

‘Erwan Cossé is very experienced and able to provide to-the-point and practical legal advice.’

‘HBC Avocats remains one of the most innovative, supportive, and proactive law firms I have encountered in my career. From general case management to contract drafting, their support has been phenomenal.’

‘The respect and dedication of the entire team are exemplary, and their respectful approach to confidentiality, ethics, and best practices is something I have personally experienced firsthand.’

‘HBC Avocats utilizes the latest technologies and offers competitive advantages for the work performed, from contract drafting and negotiation to execution.’

‘Running a business is difficult, but with the HBC lawyers by your side, it’s a continuous learning journey and an enriching experience.’

‘Erwan Cossé played a pivotal role in defining the restructuring and management of our company. Highly responsive in every respect, he answered all requests with kindness, tact, and absolute excellence. He advised the company on legal matters and contributed to our market competitiveness. Furthermore, he was always attentive to numerous points and was a pillar of the company’s strategy.’

Principaux clients

Orano Med


DNA Script


HepaRegeniX


MedInSights


VivAdju


Axplora


Novasep


Eligo Bioscience


Onward Therapeutics


Emercell


Theranexus


OSE Immunotherapeutics


Pierre Fabre


Adcytherix


InFlectis Bioscience


Inotrem


Streetlab


Blink Biomedical


Memo Therapeutics


Global Antibiotic Research and Development Partnership (GARDP Foundation)


Surfactis


Valneva


Umlaut.bio


Eukarÿs


Vital Meat


Biophytis


M CAPITAL


IRDI CAPITAL INVESTISSEMENT


OT4B


WatchFrog


Austral Dx


Axess Vision Technology


Backbone


Esprimed


Geonomy


Priothera


Stimunity


Genoskin


Herapreg


Principaux dossiers


  • Advised Theranexus on structuring, drafting and negotiating a licence and supply agreement with Exeltis (part of the Insud Pharma Group).
  • Advised Genoskin on negotiating and drafting the investment and shareholders’ agreements for its 5 M€ equity round backed by a syndicate of leading investors, including OCCTE and Captech Santé.
  • Advised Austral Diagnostics on negotiating and drafting the investment and shareholders’ agreements for its 2.5 M€ equity seed round backed by a syndicate of leading life science investors, including Audacia and Sorbonne Venture.

Jones Day

Jones Day is home to an experienced healthcare and life sciences group, led by Françoise Labrousse and Renaud Bonnet. Typical mandates for the team include M&A transactions, regulatory compliance analysis, and the protection and defence of intellectual property assets. Labrousse regularly defends clients facing regulatory enforcement actions, while Bonnet leads the team on venture capital, private equity and M&A matters. Thomas Bouvet is an experienced litigator specialising in supplementary protection certificates and standard essential patents.

Responsables de la pratique:

Françoise Labrousse; Renaud Bonnet


Autres avocats clés:

Thomas Bouvet; Colin Devinant


Les références

‘Thomas Bouvet brings a wealth of experience and is the best patent litigator in France today. He is able to be subtle or forceful, as the situation demands.’

‘A specialized multidisciplinary team with extensive collective experience.’

‘Thomas Bouvet is very insightful on a variety of topics.’

Principaux clients

PROGELIFE


BioMarin Pharmaceutical Inc.


Nanobiotix


Cellectis


ADOCIA


Bpifrance


Trill Impact


Principaux dossiers


Latham & Watkins

Latham & Watkins’ healthcare and life sciences team demonstrates wide-ranging expertise, encompassing private equity, M&A and regulatory compliance matters, as well as antitrust and data protection litigation. Leading the team, Eveline Van Keymeulen is well regarded for the depth of her expertise in key strategic legal and policy developments relating to the EU regulatory framework. Olivier du Mottay showcases strong credentials in M&A matters, in particular international private equity transactions and leveraged acquisitions.

Responsables de la pratique:

Eveline Van Keymeulen


Autres avocats clés:

Olivier du Mottay; Jeanne Fabre; Grégoire Paquet; Alexis Vaujany


Les références

‘The best team around.’

‘A responsive and available team, whose advice is very precise and tailored, always at the cutting edge.’

‘Latham’s healthcare and life sciences team, led by Eveline Van Keymeulen, distinguishes itself through its comprehensive coverage of the product lifecycle – from clinical trials to post-market obligations – and its seamless management of pan-European cases.’

Principaux clients

Coatue Management


Goldman Sachs Asset Management


TA Associates


Abbott


AbbVie


Argenx


Astorg


Bain Capital


Balt


Bridgepoint


Centessa


Direct Relief Foundation


EFPIA


ESMO


Eurazeo


Galderma


GRAIL


Ipsen


Kenvue


L’Oréal


Marinus Pharmaceuticals


MeiraGTX


Norgine


Norgine


ReCor Medical


Samsung Medison


Soterios


Swedish Orphan Biovitrum AB (SOBI)


Tempus Labs, Inc.


Veracyte


Verdiva


Whoop


Xylocor


Zo


Principaux dossiers


  • Advising EFPIA on a variety of cutting-edge legal and policy issues that are shaping the EU regulatory pharmaceutical framework.
  • Advised Bain Capital in connection with its acquisition of Softway Medical from Five Arrows Principal Investment and Naxicap Partners.
  • Advised Norgine on a definitive agreement with Theravia under which Norgine will acquire Theravia from Mérieux Equity Partners.

Linklaters

Linklaters’ wide-ranging practice encompasses M&A transactions, IP and product liability litigation, cybersecurity matters and foreign investment control advice. Pauline Debré is noted for the depth of her expertise in patent and trademark litigation, acting for clients before the national courts and the UPC. Gaëlle Bourout regularly advises biotech and pharmaceutical clients on patent issues, while Pierre Tourres specialises in public and private M&A transactions and corporate restructurings. Thomas Elkins has a high level of experience and knowledge in antitrust and foreign investment matters.

Responsables de la pratique:

Pauline Debré; Gaëlle Bourout; Pierre Tourres; Thomas Elkins


Principaux clients

Sanofi


Siemens Healthineers AG


Halozyme Therapeutics


Bpifrance


Merck & Co Inc.


Cross Border Impact Ventures (CBIV)


Carlyle


AFM Téléthon


GENFIT


McKesson


Samsung BioLogics


Principaux dossiers


Magenta

Magenta’s practice spans an array of industries, including the pharmaceutical, medtech, and cosmetics sectors. The team is recognised for its expertise in handling competition law, regulatory compliance and financial matters, ranging from market access to reimbursement issues. Gaël Hichri has a high level of experience and knowledge in competition and distribution law, frequently acting for clients in matters of anti-competitive and restrictive practices. Benjamin Jothy is a name to note for public procurement and concession contracts.

Responsables de la pratique:

Gaël Hichri


Autres avocats clés:

Benjamin Jothy


Les références

‘Gael Hichri showcases a very high level of expertise and excellent knowledge of the market environment, challenges, players, and practices.’

‘Gaël Hichri always listens and adapts to the constraints, needs, and expectations of the company.’

Principaux clients

Medtronic


Bio+


Principaux dossiers


  • Represented Medtronic in a strategic claim before the French Administrative Supreme Court, challenging the refusal of the ministers responsible for health and social security to allow Kyphon® to be reimbursed through a specific scheme known as “liste en sus” which ensures premium reimbursement conditions.
  • Successfully represented Bio+ in a strategic claim before the Administrative Court of Appeal of Lyon to challenge the decision of the Bourgogne Franche Comté regional health agency imposing a fine of EUR 1 million.

Mercure Avocats

Mercure Avocats' healthcare and life sciences practice is jointly steered by François-Maxime Philizot and Agathe Simon, with the group advising clients across the biotech, cosmetics, pharmaceuticals and medical devices sectors. Philizot is a notable contact for regulatory issues within the pharmaceutical and medical devices sectors. Simon has in-depth knowledge of matters ranging from acquisition and joint venture agreements to sellers’ warranties.

Responsables de la pratique:

François-Maxime Philizot; Agathe Simon


Les références

‘The Mercure Avocats team possesses extensive sector-specific knowledge in the life sciences industry, particularly in business and regulatory matters. It is one of the few independent firms specializing in and highly visible within this field.’

‘A very small team that is therefore very agile and dynamic, responsive, and pragmatic. They are easy to listen to and communicate with.’

‘François-Maxime Philizot particularly stands out for his pragmatic approach to contract law. He is concise, rigorous, and offers solutions. He also has a good understanding of the company’s internal challenges and has no difficulty handling highly complex and unusual cases.’

Principaux clients

Syndivia


Sanofi Pasteur


HRA Pharma


Les Laboratoires Servier


Dr Reddy’s


BPI France


Menarini Diagnostics


Biogaran


Promepla


PSL (Université Paris Sciences et Lettres)


Alira Health


LEEM


Dr Reddy’s


Bayer


White and Case


AF Genese


JIMRO Co., Ltd


Forte Capital Management


Principaux dossiers


  • Assisting Bayer HealthCare in strategic and technical issues in relation to clinical studies.
  • Advised L’Oréal on the negotiation of a tripartite development and licence agreement with a biotech and a manufacturer for research and scale-up of new molecules and ingredients.
  • Assisting the LEEM (the French professional organization representing the pharma industry) in the setting up of specific agreements relating to videos on the use of medicinal products.

Pinsent Masons LLP

Pinsent Masons LLP’s comprehensive practice encompasses patent litigation, regulatory advice, R&D collaborations, and M&A tax structuring, with the team operating across the pharmaceutical, biotech, cosmetics and medtech sectors. Camille Chiari is a name to note for domestic and cross-border private equity transactions, while Annabelle Richard covers the entire scope of data protection and cybersecurity matters. Virginia de Freitas excels in IP matters, in particular pan-European patent litigation.

Responsables de la pratique:

Virginia de Freitas; Annabelle Richard; Valérie Blandeau; Camille Chiari; Melina Wolman


Principaux clients

4D Pharma


Accord Healthcare


Teva Pharmaceuticals


Insud Pharma / Exeltis


Advanced Cell Diagnostics


Principaux dossiers


  • Representing Advanced Cell Diagnostics in an infringement action filed before the UPC against one of its main competitors in relation to kits for multiplexed, quantitative, high-resolution bioimaging in academic research, drug development, and clinical pathology and diagnostics.

Taylor Wessing

Taylor Wessing has a comprehensive healthcare and life sciences offering, allowing the team to advise on biotech, pharmaceutical and medical device patent disputes, as well as clinical trials agreements and market access matters. The department is under the leadership of Evelyne Friedel, who specialises in regulatory matters within the pharmaceutical industry. Marine Boullenger is a name to note for compliance programs and contract law, while Marc Schuler excels in data management matters. Jules Fabre joined the firm from Pinsent Masons LLP in May 2025, bringing strong expertise in domestic and cross-border patent and SPC litigations.

Responsables de la pratique:

Evelyne Friedel


Autres avocats clés:

Marine Boullenger; Marc Schuler; Jules Fabre; Marina Jonon; Louise Millot


Les références

‘They are exceptional lawyers in terms of their legal expertise, and their ability to work effectively and productively in larger teams, and interact effectively and commercially with clients. A great team to work with.’

‘Jules Fabre is an excellent strategist and has the ability to manage the progress of large and complex litigation projects while being familiar with the detail of key technical and legal aspects of the dispute. He is also very personable and a pleasure to work alongside.’

‘A highly motivated team which can do in-depth research into topics really quickly, understands clients’ requests fast and provides a lot of experience as well.’

‘Jules Fabre has excellent knowledge of the framework not only of IP and general law but also EU law and pharmaceutical legislation and regulation, as well as business acumen.’

‘Jules Fabre, Marina Jonon and Louise Millot provided excellent knowledge of the local laws and practice, with a very strong technical background and outstanding strategic and communication skills.’

Principaux clients

Accord Healthcare


Fresenius Kabi


Formycon


Inogen


Inspire Medical


Klinge


Laboratoires Thea


Pentax Medical


Shockwave Medical


Sight Sciences


Stragen


WL Gore & Associates


Zentiva


Principaux dossiers


  • Assisted with regulatory matters during the acquisition of PhysioAssist, as well as drafting Inogen and PhysioAssist’s agreements with health care professionals and healthcare institutions, in France and in Europe.
  • Advising Inspire Medical on its advertising policy, reviewing its compliance policy and drafting the agreements and documentation for French healthcare professionals and with healthcare establishments.
  • Representing Accord in a high-profile patent litigation against Sanofi in relation to its generic version of Sanofi’s blockbuster prostate cancer treatment Jevtana (cabazitaxel) before the UPC Munich Local Division.

Viguié Schmidt & Associés

Viguié Schmidt & Associés' healthcare and life sciences team demonstrates particular expertise in the pharmaceuticals, biotech and biopharmaceutical sectors. The team continue to showcase strength in advising on product liability litigation, antitrust matters and regulatory issues. Leading the team, Etienne Gouesse is well regarded for the depth of his expertise in both contentious and non-contentious matters, regularly representing clients in the administrative, civil and commercial courts. Iñaki Saint-Esteben is well known for his knowledge of antitrust law and advising on merger control matters.

Responsables de la pratique:

Etienne Gouesse


Autres avocats clés:

Iñaki Saint-Esteben


Les références

‘The team distinguishes itself through its innovative research approach.’

‘Etienne Gouesse has a great ability to anticipate issues.’

‘A highly skilled and dedicated team – attentive and available, and proactive in offering solutions tailored to individual needs.’

‘Etienne Gouesse is excellent.’

Principaux clients

Johnson & Johnson


D&A Pharma


Principaux dossiers


Bignon Lebray

Bignon Lebray‘s practice spans an array of industries, including pharmaceuticals, biotechnology, medical devices, diagnostics, and healthtech. Spearheading the practice from Lyon, Barbara Bertholet provides expertise on regulatory constraints and product distribution matters, while Nicolas Moreau specialises in advising clients on R&D and data privacy issues. Caroline Cazaux brings strong credentials in competition and antitrust issues, as well as the distribution of health products.

Responsables de la pratique:

Barbara Bertholet


Autres avocats clés:

Nicolas Moreau; Caroline Cazaux; Rachel Devidal


Les références

‘The team showcases excellent responsiveness and a very good understanding of business problems.’

‘Barbara Bertholet and Rachel Devidal are very proactive and always seek to offer the best solution.’

‘Barbara Bertholet and Rachel Devidal are understanding, insightful and provide relevant analysis and strategy, with interpersonal skills.’

Principaux clients

F-CRIN


Principaux dossiers


  • Advising a French national network that supports and structures clinical research initiatives across the country, providing regular training on regulatory frameworks applicable to pharmaceuticals, medical devices, and in vitro diagnostics, with a focus on clinical trials and in-house device manufacturing in hospitals.
  • Represented the French subsidiary of a major international manufacturer of medical devices in a dispute with URSSAF regarding contributions applicable to medical devices under Article L245-5 of the French Social Security Code.
  • Advised a French biopharmaceutical company specialised in gene and cell therapy on the negotiation of a collaboration agreement with a non-profit pharmaceutical institution for the development of a cell bank.

EY Société d'Avocats

EY Société d'Avocats is home to a highly experienced healthcare and life sciences team whose practice spans an array of industries, including medical devices, biopharmaceuticals, health insurance and research. The practice group is co-led by seasoned partners Virginie Lefebvre-Dutilleul, Guillaume Pezzali and Caroline Mercier-Havsteen. Lefebvre-Dutilleul advises on a wide array of strategic advisory and regulatory issues, from designing regulatory roadmaps to supply contracts. Pezzali strengthens the firm’s M&A capabilities, while Mercier-Havsteen excels in domestic and cross-border litigation, with specific expertise in product liability matters in the pharmaceutical sector.

Responsables de la pratique:

Virginie Lefebvre-Dutilleul; Guillaume Pezzali; Caroline Mercier-Havsteen


Les références

‘Virginie Lefebvre-Dutilleul showcases excellent responsiveness, highly specialized technical knowledge, and pragmatism.’

‘EY Société d’Avocats is one of the strongest law firms in the EY Law global network. It has a broad and deep team who have been there for many years and have a great understanding of the value of multi-disciplinary services.’

‘The firm is well served by a deep team of talented attorneys across the French practice.’

Principaux clients

Octapharma


Roquette


Inserm and Inserm Transfert


Servier Group


Arthritis4Cure


Association Inter AMC


Regeneron Pharmaceuticals Inc.


Merck KGaA


Principaux dossiers


  • Advised a French regional health agency (ARS)  on streamlining the radiology sector by coordinating over 30 radiology providers to enable the successful submission of a single establishment of medical licences (EML) application per geographical site.
  • Advised Regeneron Pharmaceuticals Inc. on implementing its entire regulatory, PV, and medical affairs infrastructure in Europe and globally in the context of the takeover of worldwide commercialization from Sanofi.
  • Advised Association Inter AMC on designing the contractual mechanisms and drafting the agreements for setting up a payment system allowing patients to avoid upfront payments to healthcare professionals.

Ginestié Magellan Paley-Vincent

Ginestié Magellan Paley-Vincent is frequently called upon by healthcare professionals and public and private healthcare institutions seeking advice on negotiating practice agreements and managing disputes. Leading the team, Nathalie Boudet-Gizardin showcases expertise in licensing, telemedicine arrangements and professional liability litigation. Fabienne Kerebel is a name to note for M&A transactions, while Camille Faour specialises in regulatory and ethical matters.

Responsables de la pratique:

Nathalie Boudet-Gizardin


Autres avocats clés:

Fabienne Kerebel; Camille Faour


Les références

‘The team showcase expertise in the healthcare sector.’

‘Nathalie Boudet-Gizardin stands out for her sectoral expertise in health law.’

‘The team are led by young and dynamic lawyers.’

Principaux clients

Cerba Healthcare


Principaux dossiers


LERINS

Covering the entire scope of healthcare and life sciences matters, LERINS is able to advise clients on M&A transactions, digital health matters, regulatory compliance, and civil litigation. Luc Castagnet, who spearheads the practice, is well versed in acquisitions, consolidations, mergers, and the formation of specialised structures in the healthcare sector. Bertrand Vorms leads on contractual and civil litigation matters, while Bruno Lorit specialises in issues relating to regulatory authorities and health insurance institutions.

Responsables de la pratique:

Luc Castagnet


Autres avocats clés:

Bertrand Vorms; Bruno Lorit


Les références

‘Exceptional responsiveness, versatility and competence.’

Principaux clients

GCS Pays de Seine


Selas Olympe Imagerie


GCS LCSH


Centre Hospitalier de Troyes


GCS Hôpital Privé de L’Aube


Hôtel Barrière


Clinique de la Vue Roanne


Sniffy


Imagerie Duroc


Unilabs


Institut Curie


Almaviva


Pôle Santé Bergère


Vivalto Santé Investissement


Audiens Groupe de Prevoyance


Principaux dossiers


  • Advised Unilabs on implementing a shareholding plan for current and future professional partners within the SELAS operating under the Unilabs Group’s medical biology network.
  • Advised GCS Pays de Seine on the takeover of a healthcare facility and the creation of a joint venture among several public and private healthcare providers, followed by post-takeover operational restructuring.
  • Advised a specialised ophthalmologic surgery centre on administrative litigation against the Regional Health Agency’s refusal to enter into a multi-year objectives and resources agreement (CPOM).

NOOA Avocats

NOOA Avocats is praised by clients for its ‘deep sector knowledge and strong cross-border capability’. The firm’s practice spans an array of industries, with the team representing pharmaceutical groups, medical device manufacturers, biotechnology companies and cosmetics manufacturers. At the helm of the practice, Marie Sanchez’s expertise ranges from advising on regulatory issues and compliance matters such as market access, to representing clients before the French civil, commercial and administrative courts as well as the European Court of Justice.

Responsables de la pratique:

Marie Sanchez


Les références

‘Marie Sanchez stands out for her strategic judgement, calm execution under pressure, and clear, business-oriented advice. She anticipates issues early and negotiates firmly without escalating. Her command of cross-border matters and regulatory detail is exceptional.’

‘‘Marie Sanchez is formidable – dedicated, experienced, and a pleasure to work with. She always goes the extra mile for her clients, because she really cares.’

‘Marie Sanchez’s team combine sharp legal analysis with real business sense. They are fast, precise, and proactive, with deep sector knowledge and strong cross-border capability. Service quality is excellent: clear scoping, transparent fees, and solutions that fit the client’s risk profile.’

Principaux clients

STADA (EG Labo)


Arthrex Inc


Bicycle Therapeutics


UIVEC


Aurora Europe GmbH


Viridian Therapeutics Inc


SIFI Group


Exelixis Inc.


Principaux dossiers


Osborne Clarke

Osborne Clarke is frequently instructed by clients across the medtech, biotech and pharmaceutical sectors, advising on matters ranging from market access to ethical and compliance programs. Spearheading the practice, Thomas Devred’s wide-ranging expertise encompasses regulatory and contractual issues, licensing and product distribution matters. Léa Masson-Boukobza is particularly skilled in compliance and regulatory issues within the pharmaceuticals and digital healthcare industries.

Responsables de la pratique:

Thomas Devred


Autres avocats clés:

Léa Masson-Boukobza


Les références

‘This team distinguishes itself through a high level of expertise, an excellent understanding of the legal and operational challenges in the pharmaceutical industry, and a remarkable ability to provide clear, relevant, and strategic advice.’

‘The team’s approach combines rigour, responsiveness, and empathy, thus creating a lasting relationship of trust with their clients.’

‘Compared to competing teams in the market, they are capable of combining legal expertise with a nuanced understanding of the economic and regulatory context (ANSM, HAS, CEPS) in the healthcare sector.’

‘The team’s ability to anticipate risks, explain them clearly, and support their clients in managing complex situations or crises is a major asset.’

‘The team demonstrates exceptional commitment, going far beyond what is expected: they truly immerse themselves in their clients’ issues. This proactive approach significantly enhances the relevance and added value of their advice.’

‘The team demonstrates innovation in the quality of service provided. This agility and openness makes them a modern, committed team focused on finding concrete and sustainable solutions.’

‘Thomas Devred has demonstrated exceptional professionalism, strategic insight, and unwavering commitment in his role.’

‘Thomas Devred consistently provides precise, forward-thinking legal advice rooted in a profound understanding of the healthcare and regulatory landscape in France.’

Principaux clients

Act For Health


Amryt Pharmaceuticals


Baxter


Corin


Elixir Medical


Fédépsad


Grifols


Ipsen


Karl Storz


Pharma&


Revolution Medicines


Samsara Vision


Santhera Pharma


Seqirus-Csl


Stratevi


Therakos


Ultragenyx


Unicancer


Principaux dossiers


  • Assisted Pharma& on a crisis management issue with the ANSM and patients’ communities triggered by significant supply tension and a possible shortage of a rare disease pharma product of major therapeutic interest which is delivered to patients under a compassionate use program.
  • Providing day-to-day support to Grifols for advice, contract negotiation and litigation, in all legal areas.
  • Representing Corin in a commercial litigation against a French commercial agent for termination of its contract.

Product Law Firm

Product Law Firm’s practice spans an array of industries, including pharmaceutical, medical devices, cosmetics and healthcare. Typical mandates for the team range from product liability litigation to clinical trial regulation and contract drafting. Paul-Henry Devèze advises on a wide array of matters concerning health product regulation, including market access, commercial agreements and product withdrawal. Antoine de Brosses regularly acts for clients in the pharmaceutical sector on regulatory and medicinal product classification matters.

Responsables de la pratique:

Paul-Henry Devèze


Autres avocats clés:

Antoine de Brosses


Les références

‘The team is indispensable in this field.’

‘Paul-Henry Devèze makes all the difference and demonstrates ingenuity.’

‘Paul-Henry Devèze demonstrates great expertise and efficiency in case management.’

Principaux dossiers


Schertenleib

Patent litigation and regulatory disputes work is at the heart of Schertenleib’s healthcare and life sciences practice, with the team acting for clients across the pharmaceutical, medical devices and cosmetics industries. Spearheading the team, Denis Schertenleib excels in multinational litigation, in particular IP matters. Ombeline Degèze-Péchade’s extensive expertise encompasses complex regulatory frameworks and covert market strategies, while Marc Lauzeral is a name to note for cross-border patent and SPC disputes.

Responsables de la pratique:

Denis Schertenleib


Autres avocats clés:

Marc Lauzeral; Ombeline Degèze-Péchade


Les références

‘The Schertenleib team consists of excellently skilled lawyers who are quick thinking with a lot of experience in the pharmaceutical and life sciences industries.’

‘The team have a deep and thorough understanding of the regulatory background and are able to provide in-depth analysis and legal advice that truly takes all relevant factors into account. They are diligent, committed, extremely knowledgeable and responsive. Absolutely recommended!’

‘Ombeline Degèze-Péchade is extremely responsive and provides brilliant advice due to her extensive knowledge and experience. Ombeline and the Schertenleib law firm are definitely a go-to address for all healthcare and life sciences related questions.’

‘Ombeline Degrèze-Péchade’s regulatory arguments and pleadings are irrefutable.’

‘Denis Schertenleib and Ombeline Degrèze-Péchade, along with their excellent team, demonstrate remarkable intellectual virtuosity and a profound understanding of both the applicable regulations and EU-related issues.’

‘From my perspective, Ombeline Degrèze-Péchade’s expertise in health product regulatory matters and Denis Schertenleib’s in patent law is clearly an asset in highly technical litigation.’

‘A competent, attentive, and adaptable team provides genuine support to the client, taking into account their specific needs and constraints.’

‘The team are tenacious and will explore every avenue for the client. Denis Schertenleib and Marc Lauzeral in particular are totally focussed on achieving great outcomes for clients and never give up.’

Principaux clients

Recor Medical Inc. & Otsuka Medical Device


Viatris


Neuraxpharm


Sandoz


Zentiva


Filorga


Fill-Med


Bio-Rad


Principaux dossiers


  • Represented Sandoz in invalidity proceedings against Bayer’s patent relating to Rivaroxaban, one of Bayer’s blockbuster drugs and a strategic product for the client’s European portfolio.
  • Represented Viatris in litigation initiated by Biogen before the Paris Court of First Instance, concerning dimethyl fumarate (DMF)—one of Biogen’s blockbuster drugs used in the treatment of multiple sclerosis.
  • Advised a major Korean biopharmaceutical company on key regulatory and competition law issues under French and EU law in connection with the launch of a leading biosimilar.

Squire Patton Boggs

Squire Patton Boggs‘ well-established client base includes companies in the pharmaceuticals, biotechnology, medical devices, digital health and research sectors. The practice group is co-led by experienced partners Carole Sportes, who specialises in investment treaty claims, commercial arbitration and M&A, and Valérie Ravit, who focuses on insurance and product liability litigation. Charles Fabry is a name to note for management incentive schemes, joint ventures and corporate restructurings.

Responsables de la pratique:

Carole Sportes; Valérie Ravit


Autres avocats clés:

Charles Fabry; Maxime Dequesne; Arnaud Moussatoff; Laure Perrin


Les références

‘Valérie Ravit has the ability to develop a comprehensive strategy for handling mass litigation, and excellent analytical and synthesis skills.’

‘Maxime Dequesne, Arnaud Moussatoff and Laure Perrin showcase advanced skills, strong responsiveness and availability. They have an excellent understanding of the issues and the ability to find solutions.’

‘A responsive team with 360-degree capabilities.’

Principaux clients

RIM (Relais Instruction Education Maroc)


Air Liquide


Principaux dossiers


  • Advised Air Liquide on the sale of its home care activity for patients in the fields of respiratory care, infusion therapy, and diabetes to ISIS.
  • Advised Air Liquide on the sale of VitalAire Japan to SOS Oxygène.

Taliens

Intellectual property law is at the heart of Taliens’ healthcare and life sciences practice, with the team advising on patent protection, regulatory compliance, and IP lifecycle management. Co-heading the firm, Jean-Frédéric Gaultier is noted for the depth of his expertise in patent infringement proceedings, while Grégoire Triet regularly advises on cross-border patent enforcement and market entry matters. Tougane Loumeau is a name to note for SPC proceedings and pharmaceutical patent litigation.

Responsables de la pratique:

Jean-Frédéric Gaultier; Grégoire Triet


Autres avocats clés:

Tougane Loumeau


Les références

‘The team stands out for its ability to combine operational rigour with strategic agility. It demonstrates a strong performance culture, based on clear objectives, regular evaluation, and a visible commitment to skills development.’

‘The team’s collaborative approach, responsiveness, and client service orientation are major assets.’

‘Within the team, two lawyers stand out in particular for the excellence of their work, their intellectual rigour, and their strategic commitment: Grégoire Triet and Tougane Loumeau.’

‘Grégoire’s Triet’s expertise is invaluable, and his analysis is always insightful and relevant. He distinguishes himself by his ability to delve deeply into cases, anticipate challenges, and propose robust and innovative legal strategies.’

‘Grégoire Triet demonstrates a keen eye for detail, technical expertise, and exemplary rigour. He is also a hard worker with an extensive network of contacts in the legal and industrial sectors, which enhances the impact of his work.’

‘Tougane Loumeau’s advice is always of excellent quality, and her strategic approach allows for confident and clear-sighted decision-making.’

‘Tougane Loumeau’s ability to dissect the technical and legal elements, structure arguments, and identify points of weakness or strength is particularly noteworthy.’

‘Tougane Loumeau’s keen insight helps strengthen a client’s position against major competitors. Her work on litigation and legal monitoring strategies demonstrates a thorough understanding of the issues at stake in our cases.’

Principaux clients

AstraZeneca


Eisai


Johnson & Johnson


Janssen


Nemera


Principaux dossiers


  • Successfully defended Nemera against compensation claims by CVA Silicone related to a halted R&D project for a testosterone treatment device.
  • Acting for AstraZeneca AB in appeals against the French Patent Office’s refusal of supplementary protection certificates for two diabetes combination products.
  • Acting for Nemera in a patent infringement matter in France and Germany against Aptar.

UGGC Avocats

UGGC Avocats' healthcare and life sciences team specialises in advising private and public health facilities on the production and distribution of health products, as well as showcasing expertise in advising on health regulations, contracts and regulatory litigation. Sylvie Welsch has a high level of experience and knowledge regarding contract and medical liability disputes. Malka Marcinkowski is well versed in both advisory and contentious competition and distribution matters within the medicines, cosmetic and medical devices sectors. Alison Leroy is a name to note for the management of IP rights, R&D contracts, and regulatory matters.

Responsables de la pratique:

Sylvie Welsch; Malka Marcinkowski; Alison Leroy


Les références

‘The team is distinguished by its high level of professionalism, responsiveness, and availability.’

‘UGGC Avocats offers comprehensive support, ensuring clients feel fully supported and guided throughout all processes. With its in-depth expertise, the team also adapts effectively to each client’s specific requirements and level of knowledge.’

‘The team showcases good knowledge of the R&D and pharmaceutical sectors, with a pragmatic, rather than theoretical, approach.’

‘Alison Leroy is a good listener who takes into account both legal and operational needs and ensures understanding before starting work.’

Principaux clients

ONIAM (Office National d’Indemnisation des Accidents Médicaux)


Paris 2024


Servier


CNX Therapeutics


SBM Company


Life Scientific Limited


AdBio Partners


Tridek-One


Bpifrance


Therinvest


Centre Hospitalier Universitaire de Guadeloupe (CHU Guadeloupe)


Advent France Biotechnology


Innothera Group


Olmix Group


DocCity


Spartners by Servier and BioLabs


Institut de Recherches Servier: Consortium EUbOPEN


Servier: Consortium C-Path


Principaux dossiers


  • Advising Institut De Recherches Servier and Biolabs on the implementation of and the launch of Spartners by Servier & Biolabs.
  • Advising Servier Group in connection with the EUbOPEN consortium, under IMI2 (Innovative Medicines Initiative), on transferring data and results resulting from the consortium’s extensive research work to a third party located in the United States.
  • Assisting AdBio Partners and Inserm Transfert in connection with their strategic alliance by launching a series of themed biotech venture studios: AndzonBio.